Use access key #2 to skip to page content.
$4.50 -0.44 (-8.91%)
10/10/2008 4:00 PM

Stereotaxis, Inc. (STXS)

CAPS Rating:
***

The Company designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite, or cath lab.

View All Commentary (STXS)

Recs

0

Avatar frogtoad (66.84) Submitted: 8/14/07 11:37 PM : Outperform Start Price: $13.28 STXS Score: -28.12

This company has a revolutionary product that is becoming the standard of care for the treatment of a heart condition known as atrial fibrillation, which is an increasing demographic as baby-boomers age. Partnerships with big boys Siemens, Philips, and J&J provide a level of comfort and possibility for a future buyout.

Report this Post Replies: 0 | Reply

Featured Broker Partners